Class II
Ongoing
Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
Why: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
- Company
- Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Orlando, FL, United States - Reported
- Jul 17, 2013
- Recall started
- May 29, 2013
- Where sold
- Nationwide and PR
- Amount
- 1
- Full product description
- Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL
- Lots / codes affected
- A5029 Exp 11/30/13
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.